1.A complex urinary fistula after Bricker ileal conduit.
Fa-Jun QU ; Jing-Fei TENG ; Xin-Gang CUI ; Yi GAO ; Lei YIN ; Yu-Shan LIU ; Ya-Cheng YAO ; Dan-Feng XU
Chinese Medical Journal 2013;126(7):1246-1246
Aged
;
Humans
;
Male
;
Urinary Diversion
;
adverse effects
;
Urinary Fistula
;
diagnosis
;
etiology
2.Current application of placebo in Chinese clinical studies in past 30 years.
Sheng-ping WU ; Li-peng XU ; Yu GUO ; Ya-shan CUI ; Xi-yan ZHAO ; Yong LI ; Xiao-lin TONG ; Feng-mei LAN
China Journal of Chinese Materia Medica 2015;40(7):1410-1414
To analyze and discuss placebo-related information in clinical research literatures in the past 30 years, including placebo's dosage form, ingredients, preparation process and quality control. Effort were made to research the CNKI. full-text database to preliminary find 700 placebo-related clinical research literature, screen out 301 eligible articles by hand, read the literatures to extract placebo-related information and make statistics and discussions. According to the results, Chinese randomized placebo-controlled clinical studies were characterized by diverse dosage forms of placebo with lack of reports for components, as evidenced by the only 17 literatures describing placebo's preparation or specific composition among the 301 literatures. Placebo-controlled clinical trials covered a wide range of disease spectra, but with a specific tropism of diseases in terms of system classification. Although placebo plays a key role in blinded clinical studies, researchers made less records of placebo, perhaps because they paid less attention to placebo or more attention to the research process or restricted by other objective conditions. Moreover, placebo production, quality control and quality evaluation also need to be further standardized.
Biomedical Research
;
history
;
standards
;
China
;
History, 20th Century
;
History, 21st Century
;
Humans
;
Placebo Effect
;
Quality Control
;
Randomized Controlled Trials as Topic
;
history
;
standards
3.Management skills of intractable ureterostenosis under ureteroscope
Ji-Zhong REN ; Dan-Feng XU ; Ya-Cheng YAO ; Yu-Shan LIU ; Yi GAO ; Lei YIN ; Xingang CUI ; Jianping CHE ; Zhilian MIN ;
Academic Journal of Second Military Medical University 2000;0(08):-
Objective:To discuss the management principles and skills for treatment of intractable ureterostenosis under ureteroscope.Methods:Our management experience on 19 patients with intractable ureteral stenosis was retrospectively analyzed.The 19 cases included urological TB-caused multiple ureteral stenosis,oncothlipsis to ureters from intestinal tract or gynecology,restenosis 3 months to 12 years after pelviureteric junction plasty,operative site stenosis after ureterolithotomy. double ureter back flow accompanied by stenosis,ureter imperforation after renal parenchyma lithotomy without placing double"J",ureter imperforation 3 months after extracorporeal shock-wave lithotripsy due to ureterolith,tubal bladder stoma stenosis after renal transplantation,restenosis after tubal bladder stoma due to distal ureterostenosis,and so on.All the patients were treated under ureteroscope.The management methods included:the Wolf 8/9.8 CH12?and Wolf 6/7.6 CH5?ureteroscope was used as a dilator to dilate the stenoses:balloon expanding under ureteroscope was used to dilate the stenoses;the ureter pliers was used to expand the stenoses to different directions;the cold knife was used to open the stenoses;if the diameter of stenoses were smaller than the that of the ureteroscopes,F4.5 or F3 double"J"tubes were inserted guided by a wire under ureteroscope; and 2 or 3 weeks later,a larger tube or two tubes were introduced into the stenoses already dilated partly by the former tube. Results:Ureteroscopic method failed in treating 2 patients in our group and succeeded in treating all the other patients.The outcomes of patient were fine during 9 months to 3 years'follow-up.Conclusion:It is difficult to treat patients with intractable ureterostenoses.With good experience in manipulation of ureteroscope,the flexible application of several techniques according to the different conditions of different patients can guarantee successful treatment in most patients.
4.Effects of jin chai antiviral capsule on IFITM3 expression in mice.
Ju-Ying ZHONG ; Xiao-Lan CUI ; Yu-Jing SHI ; Shan-Shan GUO ; Ying LIU ; Fang-Zhou LIU ; Ying-Jie GAO ; Ya-Hong JIN ; Hong-Xin CAO
Acta Pharmaceutica Sinica 2012;47(7):904-908
This study is to investigate the treatment of Jin Chai antiviral capsule for influenza virus FM1/47 (H1N1) infection. The model of pneumonia was established by dropping influenza virus into the nose of normal mice, real-time PCR and Western blot technique were used to detect the virus load and the interferoninducible transmembrane protein3 (IFITM3) in lung of mice at the 1st day, 3rd day, 5th day and 7th day after affected. The results showed that Jin Chai antiviral capsule in large, middle, small dose groups can decrease virus load significantly at each time point, after being affected (P<0.05, P<0.01), Jin Chai antiviral capsule can increase the interferoninducible transmembrane protein3 in lung of mice, large dose groups are significantly higher in expression of IFITM3 compared with model group at each time point (P<0.05, P<0.01). Middle dose groups are significantly higher in expression of IFITM3 compared with model group at the 3th day and the 5th day (P<0.05), small dose groups are significantly higher in expression of IFITM3 compared with model group at the 3th day (P<0.05). It can be concluded that Jin Chai antiviral capsule exerts antiviral effects against influenzavirus by raised expression of IFITM3.
Animals
;
Antiviral Agents
;
administration & dosage
;
pharmacology
;
Capsules
;
Dose-Response Relationship, Drug
;
Drug Combinations
;
Drugs, Chinese Herbal
;
administration & dosage
;
pharmacology
;
Female
;
Influenza A Virus, H1N1 Subtype
;
drug effects
;
Lung
;
metabolism
;
Male
;
Membrane Proteins
;
metabolism
;
Mice
;
Mice, Inbred ICR
;
Orthomyxoviridae Infections
;
metabolism
;
virology
;
Plants, Medicinal
;
chemistry
;
Pneumonia
;
metabolism
;
virology
;
Viral Load
;
drug effects
5.Effects of yin qiaojiedu soft capsule on influenza virus load and M1 expression in mice.
Ying LIU ; Yu-Jing SHI ; Han SHI ; Ju-Ying ZHONG ; Fang-Zhou LIU ; Ying-Jie GAO ; Ya-Hong JIN ; Shan-Shan GUO ; Xiao-Lan CUI
Acta Pharmaceutica Sinica 2011;46(6):650-655
This study is to investigate the treatment of YinQiaojiedu soft capsule for influenza virus A/PR8/34 (H1N1) infection. The model of pneumonia was established by dropping influenza virus into the nose of normal mice, and the lung index and death rate were observed. Real time RT-PCR and Western blotting technique were used to detect the virus load and the relative expression of M1 protein in lungs of mice on the 1st, 3rd, 5th and 7th day after infection. The results showed that YinQiaojiedu soft capsule in 1 g x kg(-1) and 0.5 g x kg(-1) dose groups can decrease the lung index significantly on the 3rd, 5th and 7th day after being infected (P < 0.05, P < 0.01), and the number of death in the two groups of animals decreased significantly. YinQiaojiedu soft capsule in 1 g x kg(-1) dose group can decreased virus load at each time point, and lower it in 0.5 g x kg(-1) dose group at the 3rd, 5th and 7th day (P < 0.05, P < 0.01). YinQiaojiedu soft capsule can decrease the relative expression of M1 protein in lungs of mice, 1 g x kg(-1) and 0.5 g x kg(-1) dose groups are significantly lower in expression of M1 protein compared with model group at the 3rd and 7th day (P < 0.05, P < 0.01). It can be concluded that YinQiaojiedu soft capsule exerts antiviral effects against influenza virus by downregulating expression of virus load and M1 protein.
Animals
;
Antiviral Agents
;
administration & dosage
;
pharmacology
;
Capsules
;
Drugs, Chinese Herbal
;
administration & dosage
;
pharmacology
;
Female
;
Influenza A Virus, H1N1 Subtype
;
Lung
;
metabolism
;
virology
;
Male
;
Mice
;
Mice, Inbred ICR
;
Orthomyxoviridae Infections
;
drug therapy
;
metabolism
;
virology
;
Pneumonia
;
metabolism
;
virology
;
Viral Load
;
drug effects
;
Viral Matrix Proteins
;
metabolism
6.Pharmacodynamic experiment of the antivirus effect of Houttuynia cordata injection on influenza virus in mice.
Fang-zhou LIU ; Han SHI ; Yu-jing SHI ; Ying LIU ; Ya-hong JIN ; Ying-jie GAO ; Shan-shan GUO ; Xiao-lan CUI
Acta Pharmaceutica Sinica 2010;45(3):399-402
It is to investigate the effect of two kinds of Houttuynia Cordata Injection on preventing and treating H1N1 influenza virus infection in mice. Pneumonia model was set up by intranasal infection of the normal and immunocompromised mice with influenza virus FM1 and PR8. The two injections were administered before and after the administration of virus, separately, and the lung index was observed. The results showed that the two preparations have obvious therapeutic effect on normal mice infected with influenza virus FM1 and PR8. And to FM1, the new injection's effect is better at small dosage. The results also showed that the two preparations have obvious prophylactic effect on immunodepressed mice infected with influenza virus FM1 and PR8. And to PR8, the old injection's effect is better at small dosage. Houttuynia Cordata Injection can improve the mice pneumonia caused by influenza virus H1N1 and decrease the lung index markedly. It has a remarkable preventive and therapeutic effect on H1N1 influenza virus in mice.
Animals
;
Antiviral Agents
;
administration & dosage
;
therapeutic use
;
Drugs, Chinese Herbal
;
administration & dosage
;
isolation & purification
;
therapeutic use
;
Female
;
Houttuynia
;
chemistry
;
Immunocompromised Host
;
Influenza A Virus, H1N1 Subtype
;
drug effects
;
immunology
;
Injections
;
Male
;
Mice
;
Mice, Inbred ICR
;
Orthomyxoviridae Infections
;
complications
;
drug therapy
;
immunology
;
prevention & control
;
Plants, Medicinal
;
chemistry
;
Pneumonia, Viral
;
drug therapy
;
etiology
;
prevention & control
;
Random Allocation
7.Effect of xuebijing oral effervescent tablet on endotoxin induced fever and disseminated intravascular coagulation rabbit model.
Shan-Shan GUO ; Ying-Jie GAO ; Xue-Chuan TIAN ; Ya-Hong JIN ; Fang-Zhou LIU ; Xiao-Lan CUI
Acta Pharmaceutica Sinica 2013;48(8):1241-1246
In order to discover the mechanism of Xuebijing oral effervescent tablet (XBJOET) to treat infectious diseases, the effect of XBJOET on endotoxin induced rabbit fever and disseminated intravascular coagulation (DIC) was investigated. Auricle microcirculation in rabbit was detected by laser speckle blood perfusion imager system; coagulation function was measured by coagulation analyzer, fibrinolytic system was quantified by Elisa assay and micro thrombosis in tissues was observed with HE staining under light microscope. The results demonstrated that the body temperature of rabbit decreased significantly at 1-3 h after administration with 4.8, 2.4 and 1.2 g x kg(-1) XBJOET to endotoxin induced DIC rabbit model, the auricle microcirculation blood flow in model group (54.45 +/- 14.53) PU was lower than that in control group (77.18 +/- 12.32) PU. The auricle microcirculation blood flow increased markedly and there was significant difference between model group and 1.2 g x kg(-1) XBJOET group. There was significant difference between model group and control group in the content of PAI1 and FIB. The PAI1 levels in model and control groups were (30.48 +/- 2.46) ng x mL(-1) and (20.93 +/- 3.25) ng x mL(-1), respectively. The FIB levels in model and control group were (3.34 +/- 1.09) g x L(-1) and (4.84 +/- 1.10) g x L(-1), respectively. The content of PAI1 in rabbit plasma decreased notably, there were significant differences between model group and 4.8, 2.4 g x kg(-1) XBJOET groups. On the contrary the content of FIB increased. XBJOET possessed pharmacological activities of curing infectious fever and DIC, the mechanism of which is related to amelioration of microcirculation disturbance, inhibition of fibrinolytic system activation and coagulation and micro thrombosis elimination.
Administration, Oral
;
Animals
;
Blood Coagulation
;
drug effects
;
Body Temperature
;
drug effects
;
Disseminated Intravascular Coagulation
;
blood
;
chemically induced
;
Drugs, Chinese Herbal
;
administration & dosage
;
pharmacology
;
Ear Auricle
;
blood supply
;
Endotoxins
;
Female
;
Fever
;
chemically induced
;
drug therapy
;
physiopathology
;
Fibrinogen
;
metabolism
;
Male
;
Microcirculation
;
Partial Thromboplastin Time
;
Plasminogen Activator Inhibitor 1
;
blood
;
Prothrombin Time
;
Rabbits
;
Tablets
;
Thrombosis
;
pathology
8.Evaluation of 80-W and 120-W GreenLight laser vaporization for benign prostatic hyperplasia in high-risk patients.
Ya-Chen ZANG ; Yu-Xi SHAN ; Bo-Xin XUE ; Dong-Rong YANG ; Jie GAO ; Chuan-Yang SUN ; Yong CUI
National Journal of Andrology 2012;18(5):436-440
OBJECTIVETo investigate and compare the effectiveness and safety of 80-W GreenLight laser vaporization and GreenLight high-performance system (HPS) 120-W laser vaporization for the treatment of benign prostatic hyperplasia (BPH) in high-risk patients.
METHODSWe allocated 290 high-risk patients with BPH to two groups to receive 80-W (n = 220) and HPS 120-W GreenLight laser vaporization (n = 70). We recorded and compared the pre-, intra- and post-operative clinical data of the two groups.
RESULTSThe operations were successful in both of the groups. There were statistically significant differences in the prostate volume, IPSS, Qmax and PVR before and after surgery (P < 0.01), but not between the two groups (P > 0.05). The operation time, lasing time and energy consumption were (56.5 +/- 22.6) min, (31.2 +/- 10.3) min and (159.8 +/- 29.0) kJ in the 80-W group, as compared with (45.1 +/- 20.4) min, (24.6 +/- 8.3) min and (134.2 +/- 23.3) kJ in the 120 W group, with significant differences between the two (P < 0.01).
CONCLUSIONGreenLight laser vaporization of the prostate is a safe and effective procedure for the treatment of BPH, and the new HPS 120-W laser therapy, with its advantages of easier operation and shorter surgical time, is an even better minimally invasive option for elderly high-risk patients.
Aged ; Aged, 80 and over ; Humans ; Laser Therapy ; adverse effects ; methods ; Male ; Prostatic Hyperplasia ; surgery ; Treatment Outcome
9.Single plus one port laparoscopic radical prostatectomy: a report of 8 cases in one center.
Yi GAO ; Dan-Feng XU ; Yu-Shan LIU ; Xin-Gang CUI ; Jian-Ping CHE ; Ya-Cheng YAO ; Lei YIN
Chinese Medical Journal 2011;124(10):1580-1582
Laparoscopic radical prostatectomy is considered the first treatment of choice for local prostate cancer due to its minimal invasion advantage. To further achieve the goal of minimal invasion, single port laparoscopic radical prostatectomy has been developed to minimize the complications associated with puncture tracks. The aim of this study was to illustrate the technique for single port laparoscopic radical prostatectomy and evaluate its efficacy and safety. We reported 8 cases of radical prostatectomy with excellent early outcome carried out in Shanghai Changzheng Hospital from June 2009 to August 2009 using a home-made multiple instrument access port and adding an additional small incision at McBurney point.
Aged
;
Humans
;
Laparoscopy
;
methods
;
Male
;
Middle Aged
;
Prostatectomy
;
methods
;
Prostatic Neoplasms
;
surgery
10.Investigation of Protective Effect of Different Bile and Their Arisaema cum Bile on Acute Lung Injury Rats Induced by LPS
Ya-chen CUI ; Li-qian SHAN ; Xiao-feng LIU ; Guo-shun SHAN ; Hui GAO
Chinese Journal of Experimental Traditional Medical Formulae 2020;26(1):125-132
Objective::To compare the protective effect of different bile (porcine bile, oxgall and sheep bile) and their Arisaema cum Bile on rats with acute lung injury, so as to provide reference for the selection of bile and the classification of decoction pieces of Arisaema cum Bile. Method::Wistar male rats were randomly divided into 8 groups (